|Last Price||Today's Change||52-Week Range||Trading Volume|
|22.45||1.14 (+5.35%)||13.02 - 22.95||119.2 thousand (Above Avg)|
Market data as of 4:04PM 12/12/13. Quotes are delayed by at least 15 min.
CORRECTING AND REPLACING Emergent BioSolutions to Acquire Cangene Corporation
12/11/2013 6:40 PM ET
Emergent BioSolutions Presents Positive Interim Phase 2 Data Evaluating Otlertuzumab (TRU-016) in Combination with Bendamustine in People with Relapsed Chronic Lymphocytic Leukemia
12/09/2013 7:00 AM ET